Company · founded 2006
Protagonist Therapeutics (United States)
Newark, United States · protagonist-inc.com
- Citations, last 5 years
- 299
- Works, last 5 years
- 55
- h-index
- 21
- Scientists listed
- 5
- Grants since 2016
- 4
Grants received
2016–2017 · research · R43
Hepcidin Mimetics for the Treatment of Iron Overload Diseases
David Y Liu · Protagonist Therapeutics (United States) · funded by National Institutes of Health
2016–2020 · research · R44
Developing the required biomarkers that define ferroportin target engagement and impact on downstream signaling for clinical translation
David Y Liu · Protagonist Therapeutics (United States) · funded by National Institutes of Health
2016–2021 · research · R44
Developing the required biomarkers that define ferroportin target engagement and impact on downstream signaling for clinical translation
David Y Liu · Protagonist Therapeutics (United States) · funded by National Institutes of Health
2015–2020 · research · R44
Developing the required biomarkers that define IL-23R target engagement and effect on downstream signaling for late stage drug development and early clinical proof-of-concept
David Y Liu · Protagonist Therapeutics (United States) · funded by National Institutes of Health